| Glenoaks Urgent Care Medical Group, Inc. | |
|
1100 W Glenoaks Blvd Glendale CA 91202-2606 | |
| (818) 242-3333 | |
| (818) 546-1056 |
| Full Name | Glenoaks Urgent Care Medical Group, Inc. |
|---|---|
| Speciality | Family Medicine |
| Location | 1100 W Glenoaks Blvd, Glendale, California |
| Authorized Official Name and Position | Peter J Parker (PRESIDENT) |
| Authorized Official Contact | 8185462626 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Glenoaks Urgent Care Medical Group, Inc. Po Box 5068 Glendale CA 91221-2068 Ph: (310) 276-4715 | Glenoaks Urgent Care Medical Group, Inc. 1100 W Glenoaks Blvd Glendale CA 91202-2606 Ph: (818) 242-3333 |
| NPI Number | 1013097120 |
|---|---|
| Provider Enumeration Date | 10/16/2006 |
| Last Update Date | 05/17/2022 |
| Medicare PECOS PAC ID | 9931269628 |
|---|---|
| Medicare Enrollment ID | O20081126000112 |
News Archive
NeoStem, Inc. an international biopharmaceutical company with operations in the U.S. and China and Progenitor Cell Therapy, LLC a privately held cell therapy company that serves the cell therapy industry from licensed, state-of-the art cell therapy manufacturing facilities in New Jersey and California today jointly announced the signing of a definitive merger agreement whereby NeoStem will acquire Progenitor Cell Therapy.
In a finding that may one day help control a major cause of death among children in developing countries, a team of researchers led by faculty from the University of Maryland, College Park and the University of Maryland School of Medicine has identified microorganisms that may trigger diarrheal disease and others that may protect against it.
Tooth decay in children is a major problem across Australia, especially so in rural, remote and Indigenous communities. Children in the Northern Peninsula Area have a particular problem partly because the plant to add fluoride to the water system is no longer in use.
The U.S. Food and Drug Administration today approved Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are unable to eat or drink. Clinolipid was granted a priority review to help alleviate a drug shortage.
In wide-ranging news about state Medicaid programs, outlets look at the controversy in Maine, the lawsuit in Texas that could have ramifications across the country, a suit in Connecticut that charges the state doesn't have enough staff to process applicants, efforts to require prompt state payments to health care providers and Kansas' realignment of its Medicaid operations.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013097120 | NPI | - | NPPES |
| AW872B | Medicaid | CA |
| Provider Name | Peter J Parker |
|---|---|
| Provider Type | Practitioner - Allergy/immunology |
| Provider Identifiers | NPI Number: 1598783789 PECOS PAC ID: 9032189899 Enrollment ID: I20040729000892 |
News Archive
NeoStem, Inc. an international biopharmaceutical company with operations in the U.S. and China and Progenitor Cell Therapy, LLC a privately held cell therapy company that serves the cell therapy industry from licensed, state-of-the art cell therapy manufacturing facilities in New Jersey and California today jointly announced the signing of a definitive merger agreement whereby NeoStem will acquire Progenitor Cell Therapy.
In a finding that may one day help control a major cause of death among children in developing countries, a team of researchers led by faculty from the University of Maryland, College Park and the University of Maryland School of Medicine has identified microorganisms that may trigger diarrheal disease and others that may protect against it.
Tooth decay in children is a major problem across Australia, especially so in rural, remote and Indigenous communities. Children in the Northern Peninsula Area have a particular problem partly because the plant to add fluoride to the water system is no longer in use.
The U.S. Food and Drug Administration today approved Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are unable to eat or drink. Clinolipid was granted a priority review to help alleviate a drug shortage.
In wide-ranging news about state Medicaid programs, outlets look at the controversy in Maine, the lawsuit in Texas that could have ramifications across the country, a suit in Connecticut that charges the state doesn't have enough staff to process applicants, efforts to require prompt state payments to health care providers and Kansas' realignment of its Medicaid operations.
› Verified 8 days ago
| Provider Name | Carolyn M Lobo |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1588711709 PECOS PAC ID: 0749362937 Enrollment ID: I20080126000168 |
News Archive
NeoStem, Inc. an international biopharmaceutical company with operations in the U.S. and China and Progenitor Cell Therapy, LLC a privately held cell therapy company that serves the cell therapy industry from licensed, state-of-the art cell therapy manufacturing facilities in New Jersey and California today jointly announced the signing of a definitive merger agreement whereby NeoStem will acquire Progenitor Cell Therapy.
In a finding that may one day help control a major cause of death among children in developing countries, a team of researchers led by faculty from the University of Maryland, College Park and the University of Maryland School of Medicine has identified microorganisms that may trigger diarrheal disease and others that may protect against it.
Tooth decay in children is a major problem across Australia, especially so in rural, remote and Indigenous communities. Children in the Northern Peninsula Area have a particular problem partly because the plant to add fluoride to the water system is no longer in use.
The U.S. Food and Drug Administration today approved Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are unable to eat or drink. Clinolipid was granted a priority review to help alleviate a drug shortage.
In wide-ranging news about state Medicaid programs, outlets look at the controversy in Maine, the lawsuit in Texas that could have ramifications across the country, a suit in Connecticut that charges the state doesn't have enough staff to process applicants, efforts to require prompt state payments to health care providers and Kansas' realignment of its Medicaid operations.
› Verified 8 days ago
| Provider Name | Arman Ossia |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1811151681 PECOS PAC ID: 6507925955 Enrollment ID: I20081030000450 |
News Archive
NeoStem, Inc. an international biopharmaceutical company with operations in the U.S. and China and Progenitor Cell Therapy, LLC a privately held cell therapy company that serves the cell therapy industry from licensed, state-of-the art cell therapy manufacturing facilities in New Jersey and California today jointly announced the signing of a definitive merger agreement whereby NeoStem will acquire Progenitor Cell Therapy.
In a finding that may one day help control a major cause of death among children in developing countries, a team of researchers led by faculty from the University of Maryland, College Park and the University of Maryland School of Medicine has identified microorganisms that may trigger diarrheal disease and others that may protect against it.
Tooth decay in children is a major problem across Australia, especially so in rural, remote and Indigenous communities. Children in the Northern Peninsula Area have a particular problem partly because the plant to add fluoride to the water system is no longer in use.
The U.S. Food and Drug Administration today approved Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are unable to eat or drink. Clinolipid was granted a priority review to help alleviate a drug shortage.
In wide-ranging news about state Medicaid programs, outlets look at the controversy in Maine, the lawsuit in Texas that could have ramifications across the country, a suit in Connecticut that charges the state doesn't have enough staff to process applicants, efforts to require prompt state payments to health care providers and Kansas' realignment of its Medicaid operations.
› Verified 8 days ago
| Provider Name | Cheng Luo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922589670 PECOS PAC ID: 9931445301 Enrollment ID: I20190107002949 |
News Archive
NeoStem, Inc. an international biopharmaceutical company with operations in the U.S. and China and Progenitor Cell Therapy, LLC a privately held cell therapy company that serves the cell therapy industry from licensed, state-of-the art cell therapy manufacturing facilities in New Jersey and California today jointly announced the signing of a definitive merger agreement whereby NeoStem will acquire Progenitor Cell Therapy.
In a finding that may one day help control a major cause of death among children in developing countries, a team of researchers led by faculty from the University of Maryland, College Park and the University of Maryland School of Medicine has identified microorganisms that may trigger diarrheal disease and others that may protect against it.
Tooth decay in children is a major problem across Australia, especially so in rural, remote and Indigenous communities. Children in the Northern Peninsula Area have a particular problem partly because the plant to add fluoride to the water system is no longer in use.
The U.S. Food and Drug Administration today approved Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are unable to eat or drink. Clinolipid was granted a priority review to help alleviate a drug shortage.
In wide-ranging news about state Medicaid programs, outlets look at the controversy in Maine, the lawsuit in Texas that could have ramifications across the country, a suit in Connecticut that charges the state doesn't have enough staff to process applicants, efforts to require prompt state payments to health care providers and Kansas' realignment of its Medicaid operations.
› Verified 8 days ago
News Archive
NeoStem, Inc. an international biopharmaceutical company with operations in the U.S. and China and Progenitor Cell Therapy, LLC a privately held cell therapy company that serves the cell therapy industry from licensed, state-of-the art cell therapy manufacturing facilities in New Jersey and California today jointly announced the signing of a definitive merger agreement whereby NeoStem will acquire Progenitor Cell Therapy.
In a finding that may one day help control a major cause of death among children in developing countries, a team of researchers led by faculty from the University of Maryland, College Park and the University of Maryland School of Medicine has identified microorganisms that may trigger diarrheal disease and others that may protect against it.
Tooth decay in children is a major problem across Australia, especially so in rural, remote and Indigenous communities. Children in the Northern Peninsula Area have a particular problem partly because the plant to add fluoride to the water system is no longer in use.
The U.S. Food and Drug Administration today approved Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are unable to eat or drink. Clinolipid was granted a priority review to help alleviate a drug shortage.
In wide-ranging news about state Medicaid programs, outlets look at the controversy in Maine, the lawsuit in Texas that could have ramifications across the country, a suit in Connecticut that charges the state doesn't have enough staff to process applicants, efforts to require prompt state payments to health care providers and Kansas' realignment of its Medicaid operations.
› Verified 8 days ago
Silva Karchikian, M.d. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 410 Arden Ave, Suite 101, Glendale, CA 91203 Phone: 818-549-9305 Fax: 818-662-8812 | |
Glendale Premier Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 W Eulalia St, #201, Glendale, CA 91204 Phone: 818-240-0601 Fax: 818-240-0687 | |
Rubin Manavi, Md, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 214 N Central Ave, Glendale, CA 91203 Phone: 818-241-0970 Fax: 818-638-0024 | |
Armen Nercessian Do Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1122 N Brand Blvd Ste 101, Glendale, CA 91202 Phone: 818-552-2011 Fax: 818-552-2012 | |
Synergy Observation Specialists Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 | |
Andy Chen M.d. A,medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1101 N Pacific Ave Ste 104, Glendale, CA 91202 Phone: 818-552-5000 Fax: 818-552-2959 |